Arthritis Research & Therapy

official impact factor 4.36

Editorial

Suppression of bone morphogenetic protein inhibitors promotes osteogenic differentiation: therapeutic implications

Manolis Heliotis and Eleftherios Tsiridis*

Arthritis Research & Therapy 2008, 10:115 doi:10.1186/ar2467

No comments have yet been made on this article.

Post a comment